ENTITY
OBI Pharma Inc

OBI Pharma Inc (4174 TT)

8
Analysis
Health Care • Taiwan
OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.
more
bullish•AGP Ltd/PK
•25 May 2026 18:52•Broker

Topline Flash Note: AGP Limited (AGP) – Management Call Key Takeaways

Topline Securities hosted a management call with the leadership team of AGP Limited, wherein the speakers for the session were Mr. Kamran Nasir,...

Logo
92 Views
Share
bullish•AGP Ltd/PK
•22 May 2026 19:00•Broker

Topline Flash Note: AGP Limited (AGP) – Corporate Reorganization; A Step To Unlock Value For Shareholders

The board of AGP has approved a transformative corporate reorganization and integration plan which is subject to further necessary approvals....

Logo
96 Views
Share
bearish•OBI Pharma Inc
•20 Jan 2023 23:22

Obi Pharma Inc (4174 TT): Inherent Pipeline Risk Has Clouded Near-Term Outlook

As the lead pipeline candidate did not meet primary endpoint in phase 2 trial and developing breast cancer vaccine is a challenging job, phase 3...

Logo
606 Views
Share
bearish•OBI Pharma Inc
•19 Jan 2017 21:58

Allegations Will Distract Management

Since our last Insight The “Fasten Seat Belt Sign” Remains On posted in December, the Shi Lin District Prosecutors Office filed insider trading...

Share
bearish•OBI Pharma Inc
•10 Dec 2016 11:58

The "Fasten Seat Belt Sign" Remains On

OBI Pharmaceuticals (4174:TT) is a biotechnology company developing treatments for cancer. The shares have declined by 44% since our last Insight...

Share
x